Salix Pharmaceuticals Outlines Data Presentations at American...

... with severe hepatic impairment (Child-Pugh C). Based on animal data, XIFAXAN may cause fetal harm. Discontinue in nursing mothers after taking into account the importance of the drug to the mother. < 10% of patients and at a higher incidence than ...

http://www.businesswire.com/news/topix/20131101005097/en